StonvexLoading…
StonvexStonvexStonvexCore line items from TJX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-02-01 | Annual 2024 2024-02-03 | Annual 2023 2023-01-28 |
|---|---|---|---|---|
Revenue | $60.37B | $56.36B | $54.22B | $49.94B |
Operating Income | $7.30B | $6.48B | $5.97B | $4.64B |
Net Income | $5.49B | $4.86B | $4.47B | $3.50B |
EPS (Diluted) | $4.87 | $4.26 | $3.86 | $2.97 |
Total Assets | $35.77B | $31.75B | $29.75B | $28.35B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $6.23B | $5.33B | $5.60B | $5.48B |
Free Cash Flow OCF − CapEx | $4.92B | $4.20B | $4.33B | $2.63B |
Shares Outstanding | 1.11B | 1.12B | 1.13B | 1.16B |